Esoteric Testing Market Size & Share, by Test Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing); Technology (Flow Cytometry, Chemiluminescence Immunoassay, Mass Spectrometry, Radio Immunoassay, DNA Sequencing, Real Time Polymerase Chain Reaction); End-user (Independent & Reference Laboratories, Hospital Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3832
  • Published Date: Mar 06, 2023
  • Report Format: PDF, PPT

Companies Dominating the Esoteric Testing Landscape

    • H.U. Group Holdings, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics
    • Healius Limited
    • Sonic Healthcare Limited
    • Thyrocare Technologies Limited
    • Fulgent Genetics, Inc.
    • Kindstar Globalgene Technology, Inc.
    • OPKO Health, Inc.
    • ARUP Laboratories

Browse Key Market Insights with Data Illustration:


In The News

  • Laboratory Corporation of America Holdings has opened a new anatomic pathology and histology (APH) laboratory in Los Angeles. Dedicated to APH laboratory testing solutions, the new lab is a Center of Excellence. Through the expansion of the laboratory, new capabilities are estimated to be added, including digital pathology enhanced by artificial intelligence (AI), multiplex immunohistochemistry (IHC), and other advanced technologies.

  • ARUP Laboratories has begun testing for monkeypox as part of its in-house testing program. Monkeypox virus (including orthopoxvirus) by PCR is a real-time polymerase chain reaction (RT-PCR) test designed to detect the DNA of orthopoxviruses, including monkeypox.

  • Fulgent Genetics, Inc. confirmed that the newly-emerging Omicron variant of the SARS-CoV-2 virus can be successfully detected using the Company's RT-PCR test. Furthermore, Fulgent believes that its Next Generation Sequencing (NGS) tests for COVID-19 can accurately identify the variant.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3832
  • Published Date: Mar 06, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of chronic and infectious diseases, coupled with the rising occurrence of rare disorders are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 12% over the forecast period, i.e., 2023-2035.

Inadequate reimbursement for esoteric tests, and stringent regulatory framework imposed by the governments are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are H.U. Group Holdings, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Healius Limited, Sonic Healthcare Limited, Thyrocare Technologies Limited, Fulgent Genetics, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by test type, technology, end-user, and by region.

The infectious disease segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying